Back to Journals » Drug Design, Development and Therapy » Volume 12

Copanlisib for treatment of B-cell malignancies: the development of a PI3K inhibitor with considerable differences to idelalisib

Total article views   HTML views PDF downloads Totals
20,268 Dovepress* 17,197+ 1,747 18,944
PubMed Central* 3,071 730 3,801
Totals 20,268 2,477 22,745
*Since 21 August 2018
Total mentioned Facebook Delicious Reddit Twitter Others
7 0 0 0 1 6

View citations on PubMed Central and Google Scholar